Sir Andrew Witty became the seventh Chancellor of The University of Nottingham on January 1st, 2013.
A Nottingham alumnus, Sir Andrew has been Chief Executive Officer of GlaxoSmithKline plc (GSK) since 2008 until 2017. He was a member of the GSK Board and Corporate Executive Team.
Sir Andrew joined Glaxo in 1985 and has held a variety of Sales and Marketing roles in the UK and abroad including working in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields. Outside of the UK, Sir Andrew has worked in South Africa, The USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore he was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star.
In 2003 he was appointed President of GSK Europe, and joined GSK’s Corporate Executive Team.
He has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he is currently a member of the Prime Minister’s Business Advisory Group and is the Lead Non-Executive Director for the Department for Business Innovation and Skills. Sir Andrew is President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) a position he took up in 2010. He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List.
He graduated from The University of Nottingham in 1985 with a joint Honours BA in Economics.
Sir Andrew succeeds Professor Yang Fujia, who served as the University’s Chancellor from 2000-2012.